# LITHIUM CARBONATE
> **ANDA202219** · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 2012-08-08
## Drug
- **FDA Application Number:** ANDA202219
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LITHIUM CARBONATE
- **Generic name:** Lithium Carbonate
- **Active ingredients:** LITHIUM CARBONATE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** PHARMOBEDIENT
- **First approval:** 2012-08-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202219)
---
*MORVS · CC0 1.0*